Drug
UT 15c
UT 15c: highest development phase Phase 2, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| UT-15C SR NCT01588405 | Phase 2 | Pulmonary Arterial Hypertension |
| UT-15C NCT01746485 | Phase 1 | Healthy |
Latest
No recent events.
Follow UT 15c on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.